Natriuretic peptides: Physiology for the clinician

Siu Hin Wan, Horng Haur Chen

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Natriuretic peptides (NPs) are a family of hormones that have significant cardiorenal properties. As an important component of blood pressure homeostasis in humans, NPs are potent vasodilatory hormones that mediate diuresis, natriuresis and cardiac remodeling (Levin et al., N Engl J Med 339(5):321-328, 1998). Neurohormonal signaling plays an essential role in cardiovascular disease. Whereas antagonism of the renin-angiotensin-aldosterone pathway, a mediator of provascocontriction, leads to improved outcomes in heart failure, the potentiation of the NPs leads to vasodilation and improved cardiac remodeling. Therefore, NPs have been investigated both as a biomarker for cardiovascular disease as well as a potential treatment agent.

Original languageEnglish (US)
Title of host publicationCardiac Biomarkers: Case Studies and Clinical Correlations
PublisherSpringer International Publishing
Pages161-172
Number of pages12
ISBN (Electronic)9783319429823
ISBN (Print)9783319429809
DOIs
StatePublished - Jan 1 2016

Fingerprint

Natriuretic Peptides
Cardiovascular Diseases
Hormones
Natriuresis
Diuresis
Angiotensins
Aldosterone
Renin
Vasodilation
Homeostasis
Heart Failure
Biomarkers
Blood Pressure

Keywords

  • Atrial natriuretic peptide (ANP)
  • B-type natriuretic peptide (BNP)
  • C-type natriuretic peptide
  • Cardiovascular properties of natriuretic peptides
  • Natriuretic peptides
  • Therapeutic modalities for heart failure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wan, S. H., & Chen, H. H. (2016). Natriuretic peptides: Physiology for the clinician. In Cardiac Biomarkers: Case Studies and Clinical Correlations (pp. 161-172). Springer International Publishing. https://doi.org/10.1007/978-3-319-42982-3_13

Natriuretic peptides : Physiology for the clinician. / Wan, Siu Hin; Chen, Horng Haur.

Cardiac Biomarkers: Case Studies and Clinical Correlations. Springer International Publishing, 2016. p. 161-172.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wan, SH & Chen, HH 2016, Natriuretic peptides: Physiology for the clinician. in Cardiac Biomarkers: Case Studies and Clinical Correlations. Springer International Publishing, pp. 161-172. https://doi.org/10.1007/978-3-319-42982-3_13
Wan SH, Chen HH. Natriuretic peptides: Physiology for the clinician. In Cardiac Biomarkers: Case Studies and Clinical Correlations. Springer International Publishing. 2016. p. 161-172 https://doi.org/10.1007/978-3-319-42982-3_13
Wan, Siu Hin ; Chen, Horng Haur. / Natriuretic peptides : Physiology for the clinician. Cardiac Biomarkers: Case Studies and Clinical Correlations. Springer International Publishing, 2016. pp. 161-172
@inbook{5858c7fe28f44b06b0205e5dbfbcd282,
title = "Natriuretic peptides: Physiology for the clinician",
abstract = "Natriuretic peptides (NPs) are a family of hormones that have significant cardiorenal properties. As an important component of blood pressure homeostasis in humans, NPs are potent vasodilatory hormones that mediate diuresis, natriuresis and cardiac remodeling (Levin et al., N Engl J Med 339(5):321-328, 1998). Neurohormonal signaling plays an essential role in cardiovascular disease. Whereas antagonism of the renin-angiotensin-aldosterone pathway, a mediator of provascocontriction, leads to improved outcomes in heart failure, the potentiation of the NPs leads to vasodilation and improved cardiac remodeling. Therefore, NPs have been investigated both as a biomarker for cardiovascular disease as well as a potential treatment agent.",
keywords = "Atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), C-type natriuretic peptide, Cardiovascular properties of natriuretic peptides, Natriuretic peptides, Therapeutic modalities for heart failure",
author = "Wan, {Siu Hin} and Chen, {Horng Haur}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-42982-3_13",
language = "English (US)",
isbn = "9783319429809",
pages = "161--172",
booktitle = "Cardiac Biomarkers: Case Studies and Clinical Correlations",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Natriuretic peptides

T2 - Physiology for the clinician

AU - Wan, Siu Hin

AU - Chen, Horng Haur

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Natriuretic peptides (NPs) are a family of hormones that have significant cardiorenal properties. As an important component of blood pressure homeostasis in humans, NPs are potent vasodilatory hormones that mediate diuresis, natriuresis and cardiac remodeling (Levin et al., N Engl J Med 339(5):321-328, 1998). Neurohormonal signaling plays an essential role in cardiovascular disease. Whereas antagonism of the renin-angiotensin-aldosterone pathway, a mediator of provascocontriction, leads to improved outcomes in heart failure, the potentiation of the NPs leads to vasodilation and improved cardiac remodeling. Therefore, NPs have been investigated both as a biomarker for cardiovascular disease as well as a potential treatment agent.

AB - Natriuretic peptides (NPs) are a family of hormones that have significant cardiorenal properties. As an important component of blood pressure homeostasis in humans, NPs are potent vasodilatory hormones that mediate diuresis, natriuresis and cardiac remodeling (Levin et al., N Engl J Med 339(5):321-328, 1998). Neurohormonal signaling plays an essential role in cardiovascular disease. Whereas antagonism of the renin-angiotensin-aldosterone pathway, a mediator of provascocontriction, leads to improved outcomes in heart failure, the potentiation of the NPs leads to vasodilation and improved cardiac remodeling. Therefore, NPs have been investigated both as a biomarker for cardiovascular disease as well as a potential treatment agent.

KW - Atrial natriuretic peptide (ANP)

KW - B-type natriuretic peptide (BNP)

KW - C-type natriuretic peptide

KW - Cardiovascular properties of natriuretic peptides

KW - Natriuretic peptides

KW - Therapeutic modalities for heart failure

UR - http://www.scopus.com/inward/record.url?scp=85009659146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009659146&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-42982-3_13

DO - 10.1007/978-3-319-42982-3_13

M3 - Chapter

AN - SCOPUS:85009659146

SN - 9783319429809

SP - 161

EP - 172

BT - Cardiac Biomarkers: Case Studies and Clinical Correlations

PB - Springer International Publishing

ER -